Menopur

Menotropin, the active ingredient in Menopur, is a gonadotropin presented as an injection solution for intramuscular or subcutaneous use. It provides exogenous FSH and LH activity to stimulate ovarian follicular development and estrogen production, supporting ovulation in women with infertility and assisting reproductive techniques such as IVF. The medication is prescribed by fertility specialists and administered under clinical monitoring.

GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, fertility clinics and pharmacies worldwide. Our distribution network ensures product integrity and regulatory compliance across regions.

Menopur (menotropin) is used in reproductive hormone therapy to stimulate ovarian function. - Infertility due to anovulation: enhances follicular growth to enable ovulation. - Controlled ovarian stimulation for assisted reproductive technology (e.g., IVF): provides coordinated FSH/LH activity to produce multiple mature oocytes. - Hypogonadotropic hypogonadism: replaces deficient gonadotropins to restore normal ovarian hormone production.

Menopur may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Injection site pain: mild discomfort or bruising at the injection site. - Abdominal bloating: transient abdominal distension. - Nausea: occasional nausea.

Serious or Rare Side Effects: - Ovarian hyperstimulation syndrome (OHSS): severe ovarian enlargement with fluid shift. - Thromboembolic events: rare blood clot formation. - Allergic reaction: rash, urticaria, or anaphylaxis.

When using Menopur, specific precautions should be observed to minimize risks and ensure optimal outcomes. - Patient selection: assess ovarian reserve and risk factors for OHSS before initiating therapy. - Monitoring: perform regular ultrasound and estradiol measurements during stimulation. - Dose adjustment: modify dose based on response and any signs of excessive stimulation. - Contraindications: avoid use in active ovarian cysts, uncontrolled thyroid disease, or estrogen‑dependent tumors. - Pregnancy testing: confirm absence of pregnancy before starting treatment. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Menopur can interact with other medicines or substances that affect hormonal balance or coagulation.

Major Interactions (Avoid): - GnRH agonists/antagonists: concurrent use may alter stimulation protocols and increase OHSS risk. - Anticoagulants: heightened risk of bleeding if severe OHSS develops.

Moderate Interactions (Monitor Closely): - Thyroid hormones: adjust levothyroxine dose as estradiol changes can affect thyroid binding. - Steroids: may mask ovarian response assessments. - Diuretics: can influence fluid balance during OHSS.